...
首页> 外文期刊>Science Advances >A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer
【24h】

A tumor-suppressive circular RNA mediates uncanonical integrin degradation by the proteasome in liver cancer

机译:肿瘤抑制圆形RNA在肝癌中介导的蛋白酶体中的无甘露来的整联蛋白降解

获取原文

摘要

Circular RNAs (circRNAs) have emerged as important regulators of various cellular processes and have been implicated in cancer. Previously, we reported the discovery of several dysregulated circRNAs including circPABPC1 (polyadenylate-binding protein 1) in human hepatocellular carcinoma (HCC), although their roles in HCC development remained unclear. Here, we show that circPABPC1 is preferentially lost in tumor cells from clinical samples and inhibits both intrahepatic and distant metastases in a mouse xenograft model. This tumor-suppressive function of circPABPC1 can be attributed to its inhibition of cell adhesion and migration through down-regulating a key member of the integrin family, ITGB1 (β 1 integrin). Mass spectrometry and biochemical evidence demonstrate that circPABPC1 directly links ITGB1 to the 26S proteasome for degradation in a ubiquitination-independent manner. Our data have revealed an uncanonical route for integrin turnover and a previously unidentified mode of action for circRNAs in HCC that can be harnessed for anticancer treatment.
机译:圆形RNA(Circrnas)已成为各种细胞过程的重要调节因子,并涉及癌症。此前,我们报告了在人肝细胞癌(HCC)中的几个失去疑难的CircrNA的发现,尽管它们在HCC开发中的作用仍然不清楚。在这里,我们表明,昼夜节目,优先于临床样品中丢失肿瘤细胞,并抑制小鼠异种移植模型中的肝内和远处转移。该循环抑制函数的循环抑制函数可归因于其对细胞粘附和迁移的抑制,通过降低整联蛋白家族的关键成员ITGB1(β1整合蛋白)。质谱和生物化学证据表明,昼夜节点将ITGB1直接链接至26s蛋白酶以以普遍无关的方式降解。我们的数据揭示了Integrin周转的不甘心路线,并且可以利用抗癌治疗的HCC中Circrnas的先前未识别的Circrnas模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号